In the present study, we investigated the association of the serum levels of the tumour markers CEA and CA 15-3 with DFS and DFD in women with breast cancer without metastases at the time of primary diagnosis, in relation to age and the established prognostic factors tumour size, lymph node status, histological grading and hormone receptor status. This evidence concerns the gene CEACAM5 and breast cancer.